angiotensin ii has been researched along with vitamin d 2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Arbeeny, C; Chen, Y; Deb, DK; Kong, J; Li, G; Li, YC; Ning, G; Sabbagh, Y; Strugnell, S; Wang, Y; Zhang, Y; Zhang, Z | 1 |
Chen, S; Gardner, DG | 1 |
Axelsson, J; Rippe, A; Rippe, B; Sverrisson, K | 1 |
Manucha, W | 1 |
Chang, J; Du, J; Ge, X; Li, X; Li, YC; Liu, W; Nie, H; Sun, Y; Wei, X; Xun, Z | 1 |
2 review(s) available for angiotensin ii and vitamin d 2
Article | Year |
---|---|
Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart.
Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Ergocalciferols; Gene Expression; Hypertrophy, Left Ventricular; Intracellular Signaling Peptides and Proteins; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Myocardium; Myocytes, Cardiac; Receptors, Calcitriol | 2013 |
[Mitochondria and oxidative stress participation in renal inflammatory process].
Topics: Angiotensin II; Animals; Apoptosis; Cytoprotection; Ergocalciferols; Humans; Kidney Cortex; Kidney Tubules; Mitochondria; Nephritis; NF-kappa B; Oxidative Stress; Renal Insufficiency, Chronic; Vitamins | 2014 |
3 other study(ies) available for angiotensin ii and vitamin d 2
Article | Year |
---|---|
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ergocalciferols; Fibrosis; Glomerular Basement Membrane; Inflammation Mediators; Losartan; Macrophages; Mice; Mice, Inbred DBA; Podocytes; Renin; Renin-Angiotensin System; Time Factors; Vitamins | 2009 |
Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcineurin Inhibitors; Chromatography, Gel; Cyclic N-Oxides; Epoprostenol; Ergocalciferols; Fluorescein-5-isothiocyanate; Free Radical Scavengers; Glomerular Filtration Rate; GTP Phosphohydrolases; Immunosuppressive Agents; Kidney Glomerulus; Male; Permeability; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Reactive Oxygen Species; rho-Associated Kinases; Spin Labels; Tacrolimus; Thiourea | 2013 |
Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Bleomycin; Disease Models, Animal; Ergocalciferols; Losartan; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vitamin D | 2021 |